Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Genomic imprinting and its effects on postnatal growth and adult metabolism.

Millership SJ, Van de Pette M, Withers DJ.

Cell Mol Life Sci. 2019 Oct;76(20):4009-4021. doi: 10.1007/s00018-019-03197-z. Epub 2019 Jul 3. Review.

2.

Neuronatin deletion causes postnatal growth restriction and adult obesity in 129S2/Sv mice.

Millership SJ, Tunster SJ, Van de Pette M, Choudhury AI, Irvine EE, Christian M, Fisher AG, John RM, Scott J, Withers DJ.

Mol Metab. 2018 Dec;18:97-106. doi: 10.1016/j.molmet.2018.09.001. Epub 2018 Sep 15.

3.

Loss of Imprinting of Cdkn1c Protects against Age and Diet-Induced Obesity.

Van de Pette M, Tunster SJ, John RM.

Int J Mol Sci. 2018 Sep 12;19(9). pii: E2734. doi: 10.3390/ijms19092734.

4.

Fetal growth restriction in a genetic model of sporadic Beckwith-Wiedemann syndrome.

Tunster SJ, Van de Pette M, Creeth HDJ, Lefebvre L, John RM.

Dis Model Mech. 2018 Nov 16;11(11). pii: dmm035832. doi: 10.1242/dmm.035832.

5.

Visualizing Changes in Cdkn1c Expression Links Early-Life Adversity to Imprint Mis-regulation in Adults.

Van de Pette M, Abbas A, Feytout A, McNamara G, Bruno L, To WK, Dimond A, Sardini A, Webster Z, McGinty J, Paul EJ, Ungless MA, French PMW, Withers DJ, Uren A, Ferguson-Smith AC, Merkenschlager M, John RM, Fisher AG.

Cell Rep. 2017 Jan 31;18(5):1090-1099. doi: 10.1016/j.celrep.2017.01.010.

6.

Impact of genetic background on placental glycogen storage in mice.

Tunster SJ, Van de Pette M, John RM.

Placenta. 2012 Feb;33(2):124-7. doi: 10.1016/j.placenta.2011.11.011. Epub 2011 Dec 7.

PMID:
22153913
7.

[Multiple sclerosis management system 3D. Moving from documentation towards management of patients].

Schultheiss T, Kempcke R, Kratzsch F, Eulitz M, Pette M, Reichmann H, Ziemssen T.

Nervenarzt. 2012 Apr;83(4):450-7. doi: 10.1007/s00115-011-3376-6. Review. German.

PMID:
22038386
8.

Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome.

Tunster SJ, Van de Pette M, John RM.

Dis Model Mech. 2011 Nov;4(6):814-21. doi: 10.1242/dmm.007328. Epub 2011 Jul 4.

9.

[MS registry in Germany--design and first results of the pilot phase].

Flachenecker P, Zettl UK, Götze U, Haas J, Schimrigk S, Elias W, Pette M, Eulitz M, Hennig M, Bertram J, Hollweck R, Neiss A, Daumer M, Pitschnau-Michel D, Rieckmann P.

Nervenarzt. 2005 Aug;76(8):967-75. German. Erratum in: Nervenarzt. 2005 Dec;76(12):1523.

PMID:
15806419
10.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group.

J Neurol. 2004 Nov;251(11):1329-39. Review.

PMID:
15592728
11.

Turkish and German patients' recall of diagnosis and therapy before and following informed consent.

Pette M, Pachaly J, David M.

Ethn Health. 2004 May;9(2):213-23.

PMID:
15223577
12.

Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study.

Stangel M, Kiefer R, Pette M, Smolka MN, Marx P, Gold R.

J Neurol. 2003 Jul;250(7):818-21.

PMID:
12883923
13.
14.
15.
16.

Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones.

Pette M, Muraro PA, Pette DF, Dinter H, McFarland HF, Martin R.

J Neuroimmunol. 1999 Aug 3;98(2):147-56.

PMID:
10430048
17.

Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood.

Kruse N, Pette M, Toyka K, Rieckmann P.

J Immunol Methods. 1997 Dec 29;210(2):195-203.

PMID:
9520302
18.

Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes.

Pette M, Pette DF, Muraro PA, Farnon E, Martin R, McFarland HF.

Neurology. 1997 Aug;49(2):385-92.

PMID:
9270566
19.

In vitro modulation of human, autoreactive MBP-specific CD4 + T-cell clones by cyclosporin A.

Pette M, Pette DF, Muraro PA, Martin R, McFarland HF.

J Neuroimmunol. 1997 Jun;76(1-2):91-9.

PMID:
9184637
20.

Autoimmune responses in peripheral nerve.

Hartung HP, Willison H, Jung S, Pette M, Toyka KV, Giegerich G.

Springer Semin Immunopathol. 1996;18(1):97-123. Review. No abstract available.

PMID:
8984683
21.

T cell antigenic and neuritogenic activity of recombinant human peripheral myelin P2 protein.

Weishaupt A, Giegerich G, Jung S, Gold R, Enders U, Pette M, Hayasaka K, Hartung HP, Toyka KV.

J Neuroimmunol. 1995 Dec 31;63(2):149-56.

PMID:
8550812
22.

Mafosfamide induces DNA fragmentation and apoptosis in human T-lymphocytes. A possible mechanism of its immunosuppressive action.

Pette M, Gold R, Pette DF, Hartung HP, Toyka KV.

Immunopharmacology. 1995 Jun;30(1):59-69.

PMID:
7591714
23.

[Immune augmenting therapy as treatment of multiple sclerosis. Warning regarding a potentially toxic alternative treatment method].

Pette M, Hartung HP, Toyka KV.

Nervenarzt. 1994 Dec;65(12):878-90. German. No abstract available.

PMID:
7854511
24.

T lymphocyte recognition sites on peripheral nerve myelin P0 protein.

Pette M, Linington C, Gengaroli C, Grosse-Wilde H, Toyka KV, Hartung HP.

J Neuroimmunol. 1994 Oct;54(1-2):29-34.

PMID:
7523445
25.

Human T lymphocytes distinguish bovine from human P2 peripheral myelin protein: implications for immunological studies on inflammatory demyelinating neuropathies.

Pette M, Gengaroli C, Hartung HP, Greiner A, Giegerich G, Toyka KV.

J Neuroimmunol. 1994 Jun;52(1):47-52.

PMID:
7515899
26.

[Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies].

Pette M, Hartung HP, Toyka KV.

Nervenarzt. 1994 Apr;65(4):271-4. Review. German. No abstract available.

PMID:
8015636
27.

Measles virus-directed responses of CD4+ T lymphocytes in MS patients and healthy individuals.

Pette M, Liebert UG, Göbel U, Grosse-Wilde H, Hartung HP, Toyka KV.

Neurology. 1993 Oct;43(10):2019-25.

PMID:
8105423
28.

The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.

Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP.

Ann Neurol. 1993 Aug;34(2):136-44.

PMID:
8338338
29.

Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.

Saruhan-Direskeneli G, Weber F, Meinl E, Pette M, Giegerich G, Hinkkanen A, Epplen JT, Hohlfeld R, Wekerle H.

Eur J Immunol. 1993 Feb;23(2):530-6.

PMID:
7679649
30.

Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein/major histocompatibility complexes.

Giegerich G, Pette M, Meinl E, Epplen JT, Wekerle H, Hinkanen A.

Eur J Immunol. 1992 May;22(5):1331. No abstract available.

PMID:
1349534
31.
32.

Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.

Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L, Wekerle H.

Neurology. 1990 Nov;40(11):1770-6.

PMID:
1700336
33.

Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.

Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H.

Proc Natl Acad Sci U S A. 1990 Oct;87(20):7968-72.

34.
35.

Myelin-specific T lymphocytes in multiple sclerosis patients and healthy individuals.

Kitze B, Pette M, Rohrbach E, Städt D, Kappos L, Wekerle H.

J Neuroimmunol. 1988 Dec;20(2-3):237. No abstract available.

PMID:
2461957
36.

[A case of ocular myiasis caused by Oestrus ovis in the region of Paris].

LAPIERRE J, PETTE M.

Bull Soc Pathol Exot Filiales. 1954;47(4):561-3. French. No abstract available.

PMID:
13230816
37.

The nutrition clinic at Medical College of Virginia.

PETTE ML.

J Am Diet Assoc. 1946 May;22:422. No abstract available.

PMID:
21025071

Supplemental Content

Support Center